COMMUNIQUÉS West-GlobeNewswire

ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

10/08/2018 - 07:31

Geneva, Switzerland and Boston, MA - August 10, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]

MDxHealth (R): MDxHealth Shareholder Transparency Declaration

10/08/2018 - 07:01

Press release Regulated information 7 August 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - August 7, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on [...]

MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire

10/08/2018 - 07:01

C ommuniqué de presse Information réglementée 7 août 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 7 août 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir reçu le 3 [...]

NeoGenomics Announces Pricing on Public Offering of Common Stock

10/08/2018 - 02:40

FT. MYERS, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten public offering of 9, [...]

MacroGenics to Present at Wedbush PacGrow Healthcare Conference

10/08/2018 - 00:00

ROCKVILLE, MD, Aug. 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Kane Biotech Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

09/08/2018 - 23:06

WINNIPEG, Manitoba, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced the engagement of Dave D. Hood, President and Chief Executive [...]

Extendicare Announces 2018 Second Quarter Results

09/08/2018 - 23:00

MARKHAM, Ontario, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2018. Results are presented in Canadian [...]

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information

09/08/2018 - 22:43

Conference Call Scheduled for Friday, August 10th at 11:00 AM EDT NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]

MediPharm Labs Continues to Strengthen Leadership Team for Growth

09/08/2018 - 22:43

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Aug. 09, 2018 (GLOBE [...]

Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:30

AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s [...]

Denali Therapeutics Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today [...]

Terra Tech Corp Reports Financial Results for the Second Quarter of 2018

09/08/2018 - 22:20

IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its second quarter [...]

Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

09/08/2018 - 22:20

Investor Conference Call on Friday, August 10th at 10:00 am ET NEW YORK and CLEVELAND, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused [...]

Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results

09/08/2018 - 22:19

Macrilen™ (macimorelin) Successfully Launched in the U.S. in July CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing [...]

Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements

09/08/2018 - 22:17

-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis -- -- Established strategic mRNA vaccines partnership with Sanofi Pasteur -- -- Completed initial public offering raising approximately $ [...]

IntelGenx Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:17

SAINT LAURENT, Quebec, Aug. 09, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the second quarter ended June 30, 2018. [...]

ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:15

End-of-Phase 2 Meeting with the U.S. FDA on Gencaro Atrial Fibrillation Development Plan Completed; Single Additional Phase 3 Trial Planned to Support NDA Submission WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE [...]

Spero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview

09/08/2018 - 22:10

Pipeline continues to advance following recent positive data from SPR994 and Potentiator Platform; SPR994 Phase 3 initiation on-track to initiate around year-end Recent Follow-on Offering and BARDA award provide cash [...]

Asterias Biotherapeutics Reports Second Quarter Financial Results and Recent Development Progress

09/08/2018 - 22:10

Company Progressing Neurology and Immunotherapy Clinical Programs Anticipates Achievement of Significant Execution Milestones in the Second Half of 2018 and Full Year 2019 to Advance the Development of its Platform [...]